Patients treated with Gilenya “show benefits”

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Patients treated with Gilenya “show benefits”

Post by MSUK » Thu Jan 14, 2016 5:34 am

New research evaluating Gilenya’s clinical efficacy, safety, and tolerability in patients with relapsing-remitting multiple sclerosis (RRMS) has largely supported its use, finding the oral drug’s efficacy in a real-world setting was comparable to results observed in Phase 3 clinical studies...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/

User avatar
CureOrBust
Family Elder
Posts: 3361
Joined: Wed Jul 27, 2005 2:00 pm
Location: Sydney, Australia

Re: Patients treated with Gilenya “show benefits”

Post by CureOrBust » Thu Jan 14, 2016 5:52 pm

..following 105 RRMS patients...
finding the oral drug’s efficacy in a real-world setting was comparable to results observed in Phase 3 clinical studies....
The efficacy and safety results of this study were found to be comparable to those observed in Phase 3 clinical trials...
So, it basically performs the same as what the much larger Phase 3 clinical trial found, ie no news. I think the manufacturers "spin doctors" had a hand in this to keep Gylenya in the "news" and on the prescription pad.

Sure, its great that it is being monitored, but hardly news.

Post Reply
  • Similar Topics
    Replies
    Views
    Last post